Literature DB >> 33662281

Intermediate clinical endpoints in localised prostate cancer.

Alison C Tree1, David P Dearnaley2, Emma Hall3.   

Abstract

Entities:  

Year:  2021        PMID: 33662281     DOI: 10.1016/S1470-2045(21)00025-5

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN: 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  2 in total

1.  PSMA PET/CT guided intensification of therapy in patients at risk of advanced prostate cancer (PATRON): a pragmatic phase III randomized controlled trial.

Authors:  Cynthia Ménard; Sympascho Young; Katherine Zukotynski; Robert J Hamilton; François Bénard; Steven Yip; Christopher McCabe; Fred Saad; Michael Brundage; Roy Nitulescu; Glenn Bauman
Journal:  BMC Cancer       Date:  2022-03-08       Impact factor: 4.430

2.  Racial and Ethnic Disparities in Prostate Cancer Outcomes in the Veterans Affairs Health Care System.

Authors:  Kosj Yamoah; Kyung Min Lee; Shivanshu Awasthi; Patrick R Alba; Cristina Perez; Tori R Anglin-Foote; Brian Robison; Anthony Gao; Scott L DuVall; Evangelia Katsoulakis; Yu-Ning Wong; Sarah C Markt; Brent S Rose; Ryan Burri; Carrie Wang; Okoduwa Aboiralor; Angelina K Fink; Nicholas G Nickols; Julie A Lynch; Isla P Garraway
Journal:  JAMA Netw Open       Date:  2022-01-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.